Actively Recruiting
Point of Care Ultrasound for the Detection of Esophageal Food Bolus
Led by WellSpan Health · Updated on 2024-07-18
30
Participants Needed
1
Research Sites
130 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This will be a prospective, observational, case-control study of adult patients presenting to the WellSpan York Hospital Emergency Department (YHED) with signs and symptoms of esophageal food or foreign body impaction. Point of care ultrasound (POCUS) will then be performed by a trained emergency physician to collect ultrasound data, including the presence or absence of direct visualization food bolus/foreign body, as well as secondary markers of dilatation, such as maximal esophageal area. Investigators will also enroll an age/sex-matched control group of asymptomatic individuals to establish baseline esophageal measurements. Patients will otherwise receive medical treatment per standard of care. Subsequent interventions will also be documented, including glucagon, carbonated beverages, and esophagogastroduodenoscopy (EGD). If patients remain in the ED and improve without need for EGD they will undergo repeat ultrasound. Chart review at 1 month will be performed to establish results of EGD including improvement, recurrence, or presence of pathologic abnormalities. The investigators aim to establish normal and abnormal parameters to aid in the diagnosis of esophageal food impactions to predict need for definitive EGD management.
CONDITIONS
Official Title
Point of Care Ultrasound for the Detection of Esophageal Food Bolus
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- For case group: signs and symptoms of esophageal food bolus or foreign body
- For control group: no signs or symptoms of esophageal food bolus or foreign body
- For control group: age and sex matched to a previously enrolled case subject
You will not qualify if you...
- Prior esophageal surgery
- History of head or neck cancer
- Incarcerated individuals
- Unable to provide consent
- Clinical instability or airway compromise
- For control group: presence of nausea, vomiting, diarrhea, abdominal pain, chest pain, shortness of breath, difficulty swallowing or pain when swallowing, or cough
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
WellSpan Health York Hospital
York, Pennsylvania, United States, 17403
Actively Recruiting
Research Team
K
Kristen Oliff
CONTACT
B
Brent Becker, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here